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ABSTRACT OF THE THESIS 
MEASUREMENT OF CAROTENOID LEVELS IN HUMAN SERUM AND A CATALOG OF 
THE LUTEIN CONFORMATION POPULATIONS FROM SEMI-EMPIRICAL 
CALCULATIONS 
by 
Vanesa Mendez 
Florida International University, 2011 
Miami, Florida 
Professor John T. Landrum, Major Professor 
Lutein is a principal constituent of the human macular pigment.  This study is composed 
of two projects. The first studies the conformational geometries of lutein and its potential 
adaptability in biological systems.  The second is a study of the response of human subjects to 
lutein supplements. 
Using semi-empirical parametric method 3 (PM3) and density functional theory with the 
B3LYP/6-31G* basis set, the relative energies of s-cis conformers of lutein were determined. All 
512 s-cis conformers were calculated with PM3. A smaller, representative group was also studied 
using density functional theory.  PM3 results were correlated systematically to B3LYP values and 
this enables the results to be calibrated. The relative energies of the conformers range from 1-30 
kcal/mole, and many are dynamically accessible at normal temperatures.   
Four commercial formulations containing lutein were studied.  The serum and macular 
pigment (MP) responses of human subjects to these lutein supplements with doses of 9 or 20 
mg/day were measured, relative to a placebo, over a six month period. In each instance, lutein 
levels in serum increased and correlated with MP increases.  The results demonstrate that 
responses are significantly dependent upon formulation and that components other than lutein 
have an important influence serum response. 
vi 
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CHAPTER 1: INTRODUCTION 
 
Carotenoids are pigments that are found in plants and microorganisms, but cannot be 
synthesized by animals [1]. These compounds are considered essential for life since they actively 
participate in the process of photosynthesis. They are responsible for the coloration in many 
flowers, fruits and vegetables. Carotenoids are also the principle pigments responsible for color in 
various animals: fish, birds’ feathers and crustaceans [2]. Although more than 750 of these 
compounds are found in the nature and they are consumed regularly in the human diet only about 
20 are detectable in human plasma and tissues [1]. 
 
1.1 Carotenoid Structures 
Most carotenoids are tetraterpenoids and contain 8 isoprenoid units [3], Figure 1. Thus 
they have a C40 carbon skeleton. The carotenoid is built up by the linking of isoprenoid units in a 
head to tail pattern to form two C20 fragments that are linked together in a head to head fashion at 
the center. Consequently, at the center the two methyl groups of the polyene chain are six carbons 
apart from each other but they are only 5 carbons apart in other rest of the molecules. 
 
Isoprene unit 
 
 
C40 Structure of Lycopene 
Figure 1. Carotenoid structure  
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C40 carotenoids are derived from lycopene by different synthetic pathways: cyclization, insertion 
of oxygen, double bond migration, methyl migration, chain elongation, and chain shortening [3]. 
Traditionally, carotenoids can be grouped into two classes: (a) carotenes or (b) 
xanthophylls. Carotenes are hydrocarbons (example: lycopene or β-carotene). Xanthophylls have 
oxygen atoms in their structure (in example: lutein and zeaxanthin).  
 
Figure 2. Carotene and Xanthophylls 
 
For carotenes, all specific names are based on the stem name “carotene”, which 
corresponds to the structure and numbering shown in Figure 3.  
Figure 3. Carotene numbering system 
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1.2 Carotenoid End-Groups 
Structurally, the carotenoids possess end-groups that are either acyclic or a ring of five or 
six carbons at one or both ends of the molecule. Carotenes are named according to  the end 
group(s) that they contain in their structures[3].  The end-groups and their prefixes are indicated 
in Table 1. 
Table 1: End-Group Designations of Carotenes. 
Type Prefix Structure 
Acyclic ψ (a) 
Cyclohexene β, ε (b, c) 
Methylenecyclohexane δ (d) 
Cyclopentene κ (e) 
Aryl φ, χ (f,g) 
 
H3C
R
CH3
CH3
R
H3C
CH3
H3C CH3
R
CH2
H3C CH3
R
CH3
CH2RH3C
H3C
CH3
R
CH3
H3C
H3C
H3C R
CH3
a b c
d (e) (f) (g)
 
Figure 4.End-groups structure 
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In green tissues, algae, and many fungi the major carotenoids are cyclic compounds such 
as: β-carotene and α-carotene. The mentioned carotenes contain ionone rings in their structure. β-
carotene has two β-ionone groups and α-carotene has one ε -ionone and one β-ionone rings.  
In xanthophylls, which contain oxygen functional groups, the compounds are named according to 
the usual IUPAC nomenclature rules, indicating the position of the oxygen containing substituent. 
For example, the name of zeaxanthin (see Figure 2) is β,β -carotene-3,3’-diol. 
 
1.3 Biosynthesis [3, 4] 
In plants, carotenoids are synthesized in the plastids by enzymes that are encoded by the 
nucleus. Carotenoids are built from the biological isoprene precursor isopentenyl pyrophosphate 
(IPP).  The first specific terpenoid precursor is mevalonic acid (MVA).  Mevalonic acid is 
converted into IPP by means of a three step enzymatic pathway; each step requires one mole of 
ATP per substrate. The first step is regulated by MVA kinase and this has been demonstrated in 
plant species and microorganisms. The identity of MVA-5-pyrophosphate, the product resulting 
from the second step, has been evidenced in yeast and has been identified as an intermediate in a 
bacterial system that can convert MVA into carotenes.  Isopentenyl pyrophosphate can be found 
in enzymatic systems capable of carotenoid synthesis, like in tomato fruit. 
To continue the chain elongation, in the first step IPP is isomerized to dimethylallyl 
diphosphate (DMAPP) by the enzyme IPP isomerase [5] (See Figure 6). The sequential addition 
of three IPP molecules to DMAPP, lengthens the chain to 10 carbons. Formation of the C15 
molecular intermediate (FPP) is catalyzed by the enzyme geranylgeranyl diphosphate synthase 
(GGPS) that links DMAPP. The enzyme is one member of a closely related family of prenyl 
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transferase enzymes that are distinguished by the length of the final product. The 20-carbon 
molecule geranyl geranyl pyrophosphate (GGPP) is generated by two identical C5 addition steps. 
 
 
Figure 5. Formation of IPP from MVA 
 
Figure 6. General pathway for the formation of phytoene [4]. The arrows on the side represent 
the enzymes involved. GGPS: geranylgeranyl diphosphate synthase. PSY: phytoene synthase.   
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The next step in the carotenoid pathway is the condensation of two GGPP molecules to 
produce phytoene, which is catalyzed by a membrane-associated enzyme, phytoene synthase 
(PSY).  Phytoene synthase shares amino-acid sequence similarity with GGPP synthase and other 
prenyl-transferases [5]. The condensation of two molecules of farnesyl pyrophosphate to produce 
squalene, the C30 precursor of sterols, is similar to the formation of phytoene from geranylgeranyl 
diphosphate synthase. In this biosynthesis pathway, NADPH is not required and one hydrogen is 
lost from C1 of each of the participating GGPP molecules. The GG residues are linked via 
sulphonium ylide. 
 
 
Figure 7. General pathway for the formation of lycopene [4]. The arrows on the side represent 
the enzymes involved. PDS: phytoene desaturase. ZDS: ζ-carotene desaturase.   
 
Four desaturation steps are required for the conversion of phytoene to lycopene and are 
catalyzed by two related enzymes in plants: phytoene desaturase and ζ-carotene desaturase. 
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However, bacteria and fungi achieve the same result via a single enzymatic complex. The first 
desaturation of phytoene produces phytofluene; then phytofluene undergoes dehydrogenation and 
isomeration to be converted into ζ-carotene. ζ-carotene is subsequently desaturated to produce 
neurosporene and lycopene. In the end the four reactions build the conjugated carbon backbone of 
lycopene. 
At this point in the biosynthesis, the pathway branches and the cyclization of lycopene 
may occur to produce either β− or ε-ring end-group structures. One branch will lead to the 
formation of β-carotene and its derivative xanthophylls, and the other branch leads to α-carotene 
and lutein. ε-carotene is also produced from δ-carotene. 
 
 
Figure 8. Cyclization of lycopene. Enzymatic conversions are shown by arrows with the enzymes 
responsible. LCY-β: lycopene beta-cyclase; LCY-ε, lycopene epsilon-cyclase; CRH-β, β-carotene 
hydroxylase; CRH-ε, epsilon-carotene hydroxylase [5].  
 
During the biosynthesis of the cyclic carotenoids, the formation of ε- and β-ionone rings 
take place at a late stage in the pathway. Experiments indicate that the β-ionone ring is formed by 
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a mechanism that involves a carbonium ion (Figure 9). The cyclization concludes with the release 
of the HB. proton from the C-6. ε-ionone is also formed by via a carbonium ion but in this case it 
is stabilized by expulsion of the HA proton at C-4 [6]. 
 
Figure 9. Basic mechanism for biosynthesis of ε and β-rings in carotenoids 
 
During the cyclization of lycopene, the reactions that are necessary for the formation of 
the carotenoid end-groups in both branches (the one that leads to lutein and the second that 
leads to zeaxanthin, Figure 8) are dependent on the relative activities of the cyclases involved in 
the reaction. The most common xanthophylls in the green tissue of higher plants, algae, and 
non-photosynthetic bacteria have hydroxyl substitutents at C-3, an oxo at C-4 or an epoxy at the 
5, 6 position of the ionone ring [7]. Genetic evidence and functional analysis of an Arabidopsis β-
hydroxylase enzyme support the existence of separate hydroxylases specific for the β- and ε-
rings.  
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1.4 Cis-carotenoids [8] 
The conjugated double bonds present in the structures of carotenoids give them the 
possibility to exist as several “cis-trans” geometrical isomers. Usually, we use cis and trans to 
indicate the orientation of substituent groups in a molecule relative to a double bond. When we 
have more than two different substituents on a double bond, E and Z are the more correct 
designations used to describe this geometrical isomerism. In nature, most carotenoids are found in 
the all-E (trans) configuration. It is also possible for the structures to have one or more than one 
“cis” or Z double bond, but these are not energetically favored.  
The β-carotene structure was elucidated by Karrer in 1930. In 1936, Gillam and El Ridi 
[9] reported in their study that when β-carotene was absorbed in an aluminium oxide column, it 
separates into two zones with different absorption maxima. They attribute this phenomenon to 
isomerization of β-carotene. With those studies the authors opened an unknown area in 
carotenoid research and from there more studies on cis and trans carotenoids were carried out. 
Further studies reported that in carotenoids other than β-carotene the same behavior was observed 
and more experimental data were presented to justify the conclusion that cis-trans isomerization 
was observed in all carotenoids. 
As stated above, many geometrical isomers can potentially arise from a single molecule 
of a carotenoid. The number of stereoisomers in an “unsymmetrical” carotenoid (like lutein) with 
“n” double bonds rises to 2n possibilities. For “symmetrical” carotenoids, we have two cases: the 
first one, when “n” is odd, the number of stereoisomers is 2(n-1)/2(2(n-1) + 1), for example β-
carotene or violaxanthin. The second one, when “n” is even, the number of stereoisomers is (2(n/2) 
– 1) (2(n/2)-1) +1), for example rodhoxanthin. 
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Figure 10. Examples of symmetrical carotenoids: (a) violaxanthin, (b) rhodoxanthin. 
In practice, there is a difference between the number of theoretically calculated and 
experimentally observed steroisomers. Experiments show that each carotenoid, after treatment to 
produce a mixture of isomers, produces only a limited number of cis isomers. The outcome of this 
reaction can be attributed to the relative energies of the all-trans (E) isomers compared to those in 
which a cis (Z) geometry is present at some point in the polyene chain.  The other important 
factor that must be considered is that proposed by Pauling. Pauling noted that isomerization can 
be favored as a result of overlapping of the methyl group of a carbon atom adjacent to a double 
bond and the hydrogen. We can explain this concept for carotenoids by looking at the backbone 
chain structure of the carotenoid, if we picture its orientation as seen in Figure 11: 
11 
 
 
Figure 11. (a) Representation of a cis double bond in the polyene chain. (b) trans-cis cases 
  
In this system A and A’ may represent two hydrogen atoms, two methyl groups or one of 
each. If both A and A’ are hydrogens (case I, Figure 11.b) the rotation around the central double 
bond will not meet any significant steric barrier in the planar cis geometry. However, if A is a 
methyl group and A’ is and hydrogen (case II, Figure 11.b) or another methyl group (case III, 
Figure 11.b) the cis geometry would have to overcome a larger energy barrier to exist.  
Isomerization from trans to cis often occurs during chemical reactions, via a thermal or a 
light activated pathway, but may it also occur via reaction with an enzyme. Geometrical 
isomerization leads to a change of shape in the carotenoid molecule. The molecule shows bending 
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and can form a zig-zag structure, see Figure 12. Presumably these shapes might have an 
important role in reactions with enzymes or with other proteins within the tissues.  
 
 
Figure 12. cis isomer of Lycopene  
 
1.5 Properties of cis carotenoids 
The following are some properties observed experimentally in cis isomers. The relative 
stability of an all-trans (E) carotenoid is greater than that of cis isomers, because of the better 
electron delocalization and the more planar nature of the chromophore configuration.  
According to Zechmeister’s study; in an all-trans carotenoid solution, the carotenoid 
undergoes isomerization continually, first to monocis, next to dicis, and so on, during that process 
the structure star bending until a polycis solution is formed. The thermostability of the carotenoid 
solution first decreases during the isomerization, and during the process it gets to a point where 
the molecule is completely bent, because of its polycis configuration. In the end the structure 
accommodates in a compact overall shape so that the thermostability increases again. 
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Figure 13. Scheme of isomerization of carotenoids. 
 
Cis carotenoids are photochemically sensitive in the presence of iodine. Studies have 
shown that the all-trans isomer has the highest melting point of all the isomers.  By comparison 
the cis conformers melt at lower temperatures. Interestingly, the decreasing of the melting point 
in a set of isomers is not proportional to the number of the cis bonds present in the molecule. 
Spectral characteristics of all-trans carotenoids and mixtures of cis-trans carotenoids were 
analyzed by Zechmeister and Polgar [10]. Natural or synthetic carotenoids were treated by reflux 
for 45 minutes.  The product was compared with an identical sample fraction that was treated 
with iodine for an hour at room temperature. It was observed that the color intensity decreased for 
the mixture of cis-trans isomers. The height and wavelength of the visible and ultraviolet maxima 
decreased in each case (Figure 14). 
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Figure 14. Molar extinction curves of β-carotene in hexane:  ___ all-trans solution. --- mixture 
of cis-trans isomers after refluxing. _._._mixture after iodine treatment [10].  
 
1.6 Naturally occurring cis carotenoid isomers. 
There are some carotenoids that have been identified in nature only as Z isomers. Bixin 
was the first cis-polyene to be recognized in nature. It is isolated from annatto seeds (Bixa 
Orellana). Pro-lycopene was first detected to exist in the tangerine tomato in 194. The tangerine 
tomato has an orange color and accumulates pro-lycopene (7Z, 9Z, 7’Z, 9’Z-tetracis-lycopene) 
instead of the all-E-lycopene that is found in most tomatoes. Photoisomerization of pro-lycopene 
occurs in chloroplasts and is associated with the existence of the photosynthetic apparatus[11]. 
Studies have focused on trying to find a particular enzyme and/or look for possible environmental 
factors that can affect the isomerization of carotenoids in plants [11],[12]. But despite all of these 
efforts to understand the mechanism of carotenoid isomerization, it remains unclear how they are 
produced. Isomeric forms of lycopene can exist as the 5-cis, 9-cis, 13-cis and 15-cis isomers [13].  
 
all-trans 
cis-trans 
mixture 
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Figure 15. Natural cis carotenoids. 
 
1.7 Bioavailability of cis-carotenoids [14] 
Isomerization produces a significant difference in molecular structures that can affect the 
bioavailability of carotenoids. In tissues, approximately equal amounts of all-E and various Z-
lycopene isomers can be found.  The Z isomers have a greater solubility in mixed micelles and are 
less likely to aggregate or crystallize; as a result they more easily become incorporated into bile 
acid micelles, increasing the efficiency of their transport to tissues.  
In fruits and vegetables β-carotene is found in the all-E form and only small amounts of 
the Z isomers are detected. The same is true for carotenoids in human plasma, but in some tissues 
Z-β-carotene isomers accumulate to significant levels. These observations may be to the result of 
various factors such as a differential uptake of cis isomers, as well as differences in their 
absorption from the gut and transport in the human blood stream. Studies in gerbils after 
including β-carotene and vitamin A in the diet showed that the amounts of (9Z) - and (13Z)- β-
carotene found in the liver were nearly equal to the amount of all-E β-carotene. An in vitro model 
of digestion showed that the incorporation of Z isomers of β-carotene into micelles were 2-3 
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times more efficient than the E form. Lutein and zeaxanthin have been found in their cis isomers 
form: (13 Z)- and (13’Z)- lutein isomers; (9Z)- and (9’Z)- lutein; and (13-Z)- zeaxanthin in 
processed fruits, vegetables and pasta food products [15]. It has been demonstrated that trans-cis 
isomerization is an effect of the thermal processing of vegetables and fruits [16]. Studies [17, 18] 
have isolated the previous mentioned cis isomers of lutein and zeaxanthin (including 15Z- 
zeaxanthin) in human serum and milk. Although the quantities isolated are lower in comparison 
with the all-E isomers, it is shown that those xanthophylls isomers also exist in the human tissues. 
 
1.8 Macular Pigment Carotenoids (MPC) 
Lutein and zeaxanthin are two yellow carotenoids that give the macular area of the retina 
its color. The reason they are known as macular pigment carotenoids is that they are selectively 
accumulated in this part of the eye. The concentration of the macular pigment in the central retina 
approaches 1 mM, more than 1000 times that in human serum and liver[19]. 
 
Figure 16. Representation of the human retina.  
(From: http://www.gene.com/gene/products/education/tgr/eye-health-glossary.html)  
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The difference between these two molecules that compose the macular pigment is the 
location of one double bond in one of the end-groups and also the configuration of the hydroxyl 
group in that particular ring. Bone and Landrum showed that the major components of the 
macular pigment were lutein [(3R,3'R,6'R)- β,ε-Carotene-3,3'-diol], zeaxanthin  [(3R,3'R)- β,β-
Carotene-3,3'-diol] and meso-zeaxanthin [(3R,3'S)- β,β-Carotene-3,3'-diol][20].  Neither humans 
nor animals can synthesize carotenoids, so they must obtain them exclusively from their diet. 
Green leafy vegetables, fruits, and egg yolk are the primary sources of lutein and zeaxanthin 
available in nature.  
 
Figure 17. Major components of the macular pigment [20]  
The content of lutein, zeaxanthin, and meso-zeaxanthin in the retina is approximately 
36%, 18%, and 18% respectively of the total carotenoid in the retina[21]. These carotenoids are 
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concentrated in the fovea, which is the depression located in the retina coinciding with the 
position of maximum visual acuity.  
Lutein and zeaxanthin can be characterized by their UV-visible spectra (Figure 18). The 
spectra may seem very similar but the presence of two β-ionone rings at the ends of the of the 
zeaxanthin structure extend the conjugation of the polyene chain and lower the energy separation 
between the ground and excited state, shifting its spectrum slightly to the red. Lutein absorbs at a 
slightly shorter wavelength than zeaxanthin.  
 
Figure 18. Spectra of lutein and zeaxanthin in ethanol[21]. 
On the basis of the spectra we can state that both carotenoids can filter blue light 
effectively.  The retina is susceptible to oxidative stress because of the high demands for oxygen 
and its constant expose to light. A principal function of lutein and zeaxanthin as macular 
pigments appears to be the protection of the retina against photo-induced damage by acting as 
antioxidants in addition to their role as a filter for blue light. 
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1.9 Transport and distribution of MPC 
The absorption of lutein and zeaxanthin occurs in the enterocytes (intestinal absorptive 
cells) of the intestinal mucosa.  They enter the hepatic portal circulation in the form of 
chylomicrons [22].  In the liver, low and high density lipoproteins (LDL, HDL) are synthesized 
and transport lutein and zeaxanthin to other tissues. It has been demonstrated that HDL is the 
primary carrier of lutein and zeaxanthin and that LDL is principally responsible for the 
transportation of carotenes[23]. Dietary lutein may be metabolized to produce meso-zeaxanthin 
within the retina, although the exact mechanism is still unknown[20]. A clear pathway of how 
these carotenoids are transported to the retina is still not well-defined.  Li et al.[24] proposed a 
possible pathway for the uptake, transport and accumulation of these macular pigments 
carotenoids in the retina based on their studies on carotenoid-binding proteins. They suggest that 
the uptake of carotenoids within the cholesterol containing lipoproteins is mediated by HDL and 
HDL receptors, such as SR-BI (a cell surface glycoprotein that binds HDL).  The mechanism 
would result in the delivery of lutein and zeaxanthin to the retinal pigment epithelium (RPE).  
From the RPE a pathway analogous to the transport of retinoids within the retina is suggested for 
lutein and zeaxanthin. Accumulation of the MPC in the retina may be similar to a pathway known 
to deliver lutein to the silk glands in silkworms.  In these larval insects, lutein is delivered to the 
silk gland via a pathway involving specific cell-uptake and specific binding proteins.  
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Figure 19. Scheme of possible pathway for the uptake, transport, and accumulation of the 
macular carotenoids in the human retina. RPE (retinal pigment epithelium). 
As a general pathway for absorption and metabolism of carotenoids in animal models 
[25], it is known that after the consumption of carotenoids from the daily diet, these are 
incorporated in a complex food matrix with proteins and lipids, because of their lipophilicity. 
After the food matrix is digested, carotenoids will be combined with lipids and bile salts to form 
micelles. The micelles will move to the intestinal brush border membrane, and carotenoids will be 
captured and transported into the enterocyte to be metabolized and secreted into the intestinal 
lumen (cavity where the nutrients are absorbed) where they will be incorporated to chylomicrons 
and secreted into the lymph. Chylomicrons take the carotenoids to the liver where they can be 
processed by the liver and stored there or resecreted in VLDL (very low-low density-lipoprotein) 
and then to the bloodstream in the form of LDL and HDL. Carotenoids can also be captured by 
extra-hepatic tissues before they are taken to the liver. Lutein and zeaxanthin will be transported 
with HDL in the bloodstream, and the uptake of lutein and zeaxanthin on RPE cells will be 
mediated by the SR-B1 (scavenger receptor class B member 1, is a receptor for HDL) [24]. The 
 
 food  
matrix 
  intestine 
 blood
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micelles 
choroid retina 
RPE 
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selection of these carotenoids is probably determined by the selective binding proteins GSTP1 
[24] (glutathione s-transferase P1) and StARD3 (steroidogenic acute regulatory domain protein 3) 
to mediate this process [26]. Experiments show that human GSTP1 exhibits a high affinity for 
zeaxanthin, and human StARD3 proteins bind lutein. Recently Bernstein’s research group 
identify StARD3 as a lutein-binding protein in the macula of the primate retina[26]. Antibody 
labeling of retina cross-sectioned reveals that these proteins are found distributed in the same 
structures as the macular pigment. 
 
1.10 Age-Related Macular Degeneration (AMD) 
Age-Related Macular Degeneration is a disease that affects the central visual acuity. It is 
associated with age and is the leading cause of blindness in people over 65 years old [27].  Age-
Related Macular Degeneration is associated with abnormalities in the retina, degeneration of the 
RPE, and ultimately loss of the photoreceptors. Low levels of macular pigments appear to be a 
risk factor for AMD [28]. Studies report that high carotenoid intake is associated with a 43% risk 
reduction for exudative AMD. Lutein and zeaxanthin have been shown to be the most strongly 
associated, among all the carotenoids studied, capable of reducing the risk for AMD [29]. The 
AREDS N°22 reported that participants with highest dietary intake of lutein and zeaxanthin were 
half as likely to have an advanced AMD as those with the lowest intake [30]. 
One of the principle reasons for our study of lutein and zeaxanthin is the properties that 
enable them to reduce the risk of AMD. A central characteristic of MPC is their ability to filter 
blue light. Blue light strikes the human retina and causes photooxidative damage to the lipid 
components of the photoreceptors disk membranes, which is a demonstrated characteristic of the 
pathology of AMD[21].  
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1.11 Principal properties of carotenoids [31, 32] 
As we mentioned above, carotenoids have an important role protecting cells and 
organisms against damage by light and reactive oxygen species (ROS) generated by light. The 
presence of conjugated double bonds in the structure of carotenoids is responsible for their most 
distinctive characteristic, light absorption [33].  
Carotenoids can quench or inactivate the excited states of molecules. Krinsky explained 
how carotenoids can perform as antioxidants by reacting with active oxygen species in 
photobiological systems [32]. 
Carotenoid quenching of singlet molecular oxygen (1O2) 
The molecule O2  is required for all aerobic cell metabolism in nature. However, the 
excited state form of O2 singlet oxygen (1O2), is an unstable and highly reactive molecule 
particularly toward many biological substrates. The unstable form of oxygen can react with 
phospholipids compounds, that can be found in the biological cells [34]. Cell damage is 
frequently mediated by the formation of 1O2 in photosensitized reactions. To explain how it is 
formed, it is helpful to understand the different states in the O2 molecule. In the ground-state, O2 
has two electrons in two separate π orbitals with their angular momentum opposed but with 
parallel spins. This ground-state is designated as the 3Σ because O2 exists as a triplet molecule 
and is a diradical. In the lowest excited state, 1Δ, the two electrons share a single orbital and they 
have the same spin. Since the electrons in this state are paired in accordance with the Pauli 
principle, the molecule is in a singlet state. O2 also has a second singlet state, 1Σ.  This state has a 
lifetime of only 1x10-11s and decays to the 1Δ state.  
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Figure 20. Diagram of the states of the O2 molecule. 
When light strikes a biological system that contains an appropriate sensitizer (S) the 
energy of the photon can convert the sensitizer to an electronically excited form (1S). The singlet 
excited states for most molecular species are very short-lived, typically measured in nanoseconds 
(<10 ns usually).  By intersystem-crossing the singlet excited states, 1S, can often be efficiently 
coverted to a longer lived triplet excited state, 3S (Equation 1).  
 
S  1S  3S   (1) 
The 3S can initiate Norrish Type I or Type II photochemical reactions. In type I reactions 
the triplet sensitizer initiates radical reactions by abstracting an electron or hydrogen atom from 
nearby biomolecules creating reactive radical species (Equation 2). In the Type II reaction, the 
triplet sensitizer reacts with molecular oxygen. Since O2 is also a triplet species, formation of the 
highly reactive 1O2 can occur renegerating the ground-state sensitizer (Equation 3), conserving 
the total spin of the system as required by quantum mechanics. 
            S+ 
 
 Type I:  3S +    biomolecule        SH·    (2) 
     R·    
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1Σ 2nd. excited state 
  life time ~ 1x10-11s  
3Σ ground state  
1Δ    1st  excited state 
  life time ~ 3-100µs  
O2 π*  
O2 π*  
O2 π*  
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Type II: 3S + 3O2   1S + 1O2   (3) 
 
Ground state carotenoid pi bonds (singlets) interact readily with 1O2, accepting the excess 
energy from this reactive excited state. In this physical quenching of the oxygen excited state the 
carotenoid absorbs the energy from the 1O2 and the result is the formation of the triplet state 
carotenoid (Equation 4).  This reaction conforms to quantum mechanical restrictions that forbid a 
net change of spin state during any allowed process. 
 
1CAROTENOID   + 1O2   3CAROTENOID + 3O2 (4) 
 3CAROTENOID     1CAROTENOID    +      heat   (5) 
 
The presence of the conjugated polyene chain in the carotenoid enables these molecules 
to readily dissipate the energy through rotational and vibrational transitions and through collisions 
with the solvent liberating the excess energy harmlessly as heat. Thus the triplet carotenoid 
returns to its ground state unaltered (Equation. 5).  
As we can see, the carotenoid may act as an antioxidant by neutralizing the potentially 
harmful 1O2 molecule in tissues and cells. Our research is concentrated on lutein and zeaxanthin 
and its importance to living organisms.  
In an effort to understand the nature of these two molecules in nature, and the uptake and 
transport of lutein and zeaxanthin in the human body we conducted two studies.  The first is a 
theoretical study. We have cataloged the different possible conformations of the lutein molecule 
model resulting from s-cis geometries in the polyene chain.  The goal of this study is to provide a 
better understanding of the possible interactions of carotenoids within the environment in the cell. 
The second part of this thesis addresses an applied project in which we studied the bioavailability 
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of lutein and the relationship of the levels of six major carotenoids in human serum before and 
during supplementation with lutein.  
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CHAPTER 2: A CATALOG OF THE RELATIVE ENERGIES OF LUTEIN 
CONFORMATION POPULATIONS 
 
2.1 Overview: 
Carotenoids are characterized by the presence of a polyene chain, typically having 9 
conjugated double bonds, predominantly having an all-E (or all-trans) configuration. These 
structures can acquire different conformations because of the rotation around the single bonds. 
The IUPAC defines s-cis, s-trans conformation as: “the spatial arrangement of two conjugated 
double bonds about the intervening single bond is described as s-cis if  syn-periplanar and s-trans 
if anti-periplanar” [35], see Figure 21.  
(a)
(b)
s-cis s-trans
(c)
 
Figure 21. (a) 1,3-butadiene  (b) 2-methyl-1,3-butadiene (c) 1,3-pentadiene. 
 
The energetic barrier between the s-trans and s-cis conformations in simple conjugated 
systems like 1,3 butadiene is low. The enthalpy difference between the s-trans and s-cis was  
27 
 
calculated in an ab initio study using the basis set 3-61G** and it was estimated to be about 16.26 
kJ/mol (3.89 kcal/mol) [36].  The classical model, for conjugated systems with methyl 
substitution, 2-methyl-1,3-butadiene is informative. The s-trans and s-cis conformers of 2-
methyl-1,3-butadiene are separated by a barrier estimated to be about 24.2  kJ/mole (5.8 
kcal/mol). 
 The addition of a methyl group in the system on C-2 has little effect on the enthalpy 
difference between the s-cis and s-trans conformers for these butadienes (Figure 21).  The 
conformational equilibrium between the s-cis and s-trans conformers of 2-methyl-1,3-butadiene 
(see Figure 21b) has been calculated to be 1.78 ± 0.15 kcal/mol using an UV absorption 
spectroscopic method [37]. However, the ab initio study of the conjugated hydrocarbons, 2-
methyl-1,3-butadiene and 1,3-pentadiene (methyl at C1 of 1,3-butadiene) showed that the energy 
difference of the s-cis and s-trans conformer are 3.38 kcal/mol and 3.87 kcal/mol 
[38]demonstrating the importance of the position of the methyl to the energy of these conformers. 
The presence of methyl substituents on the carotenoid polyene chain and the more extensive 
conjugation compared to these simple dienes is expected to significantly alter the energetics of 
the accessible conformations and the barrier to inter-conversion between conformers [39].   
 
 
 
Figure 22. Lutein single bonds assigned numbers are shown by red arrows. 
s-trans
s-cis 
1         3     5 7           9 
2         4      6   8
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The existence of 9 ‘single’ bonds between the double bonds of the polyene chain (in lutein) 
makes possible the existence of numerous conformational geometries that correspond to rotation 
about these “single” bonds. In lutein, 512 conformations are possible, when considering the 
possible combinations of s-cis and s-trans conformations at the single bonds located along the 
backbone of the polyene chain. 
In plants, fungi and invertebrates some carotenoid-binding proteins have been identified and 
characterized [40]. But in animals, carotenoid-binding proteins are still only poorly studied. 
Carotenoids in the circulation are transported in association with the lipoproteins. For example, 
the pathway that carotenoids like lutein and zeaxanthin follow to accumulate in the macula is not 
well-known.  Serum lipoproteins and their receptors are known to be involved in the uptake and 
transportation of carotenoids in the humans and animals [41].   We can infer that the process of 
carotenoid binding to proteins requires dynamic mobility and their rapid interaction with the 
membrane proteins and enzymes within the photosynthetic apparatus of plants supports this 
conclusion. Since carotenoids can accumulate in cellular membranes, we also expect that their 
conformational flexibility will influence the rate and ability to repartition into other cellular 
organelles and proteins, both membrane-bound and water soluble. Thus, the affinity of 
carotenoids for binding to a protein and the rate of that process will be influenced by the energetic 
accessibility of conformations that favor the binding process. Carotenoids are often thought of as 
rigid, rod-like molecules, but they have a degree of flexibility that influences the dynamics and 
thermodynamics of their interaction with their environment. In this study, in an approach to 
develop a better understanding of how carotenoids interact with their environment and to 
highlight the importance of conformation in carotenoid binding, we conducted theoretical 
calculations on the energetics of conformations of the lutein. We calculated the minimum energy 
optimization profiles for all of the conformational geometries involving s-cis bonds. We created a 
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catalog including all the different combinations of s-cis conformers for lutein. In order to 
accomplish this we have conducted our calculation using the complete carotenoid structure (as 
opposed to small molecule fragments) with the semi-empirical parametric method 3 (PM3)[42]. 
To validate the semi-empirical approach we have also performed a number of calculations using 
density functional B3LYP/6-31G* level of theory. We used the program Gaussian 09 Revision 
A.02 [43] for the B3LYP/6-31G* calculations. Semi-empirical methods are most useful for a 
comparative or qualitative understanding and have limitations that can invalidate their application 
in certain cases or influence the applicability of the calculation to particular systems.   
Semi empirical methods, such as PM3, use parameters derived from experimental data to 
simplify the calculations and approximations needed to solve the Schrodinger equation. The PM3 
is a level of theory that can be readily used for large molecules. In the past, PM3 has been used to 
calculate optimized 3-dimensional geometries and energy state descriptors of molecules in 
Quantitative Structure-Activity Relationship (QSAR) studies [44]. PM3 calculations are based on 
mathematical approximations. Density functional theory, on the other hand, is widely accepted to 
have better accuracy than semi-empirical methods. They compute electron correlation using 
general functions of electron density [45]. Becke’s three-parameter hybrid functional (B3LYP) is 
a hybrid functional and is used to determine the electron density within a molecule. [45]. The 
B3LYP method has been proven to be a superior approach when compared with the semi-
empirical methods but is a time-consuming method. Density functional theory is more useful in 
that it can predict diverse molecular properties: vibrational frequencies, ionization energies and 
magnetic properties, etc.  It has become more commonly used in computational chemistry over 
the past 10 years. 
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2.2. Research Methodology 
2.2.1. Geometry optimization using the semi-empirical theory: PM3 
Geometry optimizations were calculated for lutein conformers using the program 
Hyperchem 8 [http://www.hyper.com/?tabid=360] Lutein was modeled in Hyperchem and the 
initial geometry was optimized to the minimum energy using the molecular mechanics (MM+) 
force field method. Once an optimized geometry was obtained by the MM+ method, the energy of 
the molecule was minimized using the semi-empirical PM3 calculation. 
 
Figure 23. Optimized lutein model 
 
After a geometry optimization of the all-trans structure was performed, we used that 
optimized lutein structure as the starting point to generate the various conformers by rotating 
around the single bonds in the molecule. The chosen bond(s) is set to 0° (the planar s-trans 
geometry is 180° and the s-cis is 0°). In the next step we allowed the calculation to find to the 
minimum energy of the geometry selected.  For simplicity, in describing the various conformers, 
we number the nine single bonds within the polyene one through nine (see Figure 22) and name 
the conformers according to the single bond that has the s-cis conformation.  For example, the 
conformer below is labeled tri-s-cis-2,4,9 because it is a molecule having three s-cis single bonds 
in the polyene system located at the 2nd, 4th, and 9th single bonds as numbered from left (β-ring) to 
right (ε-ring) (Figure 24). 
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  Figure 24: tri s-cis 2,4,9 lutein conformer. 
 
The Tables numbered 4-27 are grouped according to the number of s-cis bonds present in the 
structures and provide a straight-forward way to group the data that resulted from our 
calculations.  We have also created graphical representations that enable us to conceptualize a 
surface for each group of molecular conformers and recognize patterns that result from the 
placement of the s-cis bonds in different locations and/or combinations. 
 
2.2.2. Geometry optimization using the density functional theory: B3LYP/6-31G*.   
The results obtained from the PM3 calculations for some selected conformers were 
compared using the B3LYP/6-31G* computational method within the Gaussian 09 Revision A.02 
program.  
To run these calculations we used a Gaussian z-matrix format to specify the molecular 
geometry of the conformers. The z-matrix is derived by the Cartesian coordinates produced by 
the PM3 optimized geometries for the selected lutein conformers. The first line of the matrix, 
represented by two integers, specifies the charge and spin multiplicity of the molecule. The next 
lines indicate the atom, represented by its nominal atomic mass. And the location of the atoms is 
represented by the cartesian coordinates. 
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2.2.3. Calculation of the energy rotational barrier 
The conformers that were selected for validation using B3LYP were chosen on the basis 
of their energy patterns.  A number of conformers had remarkably low energies as calculated by 
the PM3 method and validation of these was an important step.  Similarly, some of the 
conformers had surprisingly higher energies and these too needed to be validated.  Energy 
barriers for rotation around specific single bonds were calculated using the B3LYP/6-31G*  
method at the following torsion angles: 0°, 30°, 60°, 90°, 120°, 150°, and 180°. A z-matrix was 
constructed for this purpose. 
 
 
 
 
 
Figure 25: Rotation about the 5th single bond in lutein.  
 
 
 
2.3. Results 
2.3.1. Calculations for the basic conjugated system 
Table 2 shows the calculations run for the s-cis and s-trans conformers of 1,3-butadiene, 
2-methyl-1,3-butadiene, and 1,3-pentadiene (see Figure 21) using the PM3 method and Table 3 
shows the calculations using B3*LYP theory. 
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Table 2: Calculations using PM3 theory. 
PM3 1,3 butadiene 2-methyl-1,3-butadiene 1,3-pentadiene 
s-cis 
(kcal/mol) 
-964.5380 -1249.2777 -1248.4794 
s-trans 
(kcal/mol) 
-965.2665 -1248.7766 -1250.3684 
∆E kcal/mol 0.7285 0.5011 1.8990 
 
Table 3: Calculations using B3*LYP theory. 
B3*LYP 1,3 butadiene 2-methyl-1,3-butadiene 1,3-pentadiene 
s-cis 
(kcal/mol) -98038.7021 -122750.8496 -122749.6427 
s-trans 
(kcal/mol) -98042.5878 -122754.5361 -122754.1306 
∆E kcal/mol 
3.8857 3.6865 4.4879 
 
The relative energies are compared for each of the three cases. The absolute energies calculated 
by the two methods cannot be compared because we are using two different theories. The semi-
empirical method only takes in account the valence electrons, while the density functional method 
uses all the electrons involved in the structure. This is why we can see a big difference between 
the values obtained in each case. 
 
2.3.2. Calculations for the complete carotenoid model using PM3. 
The following tables are grouped according to the number of s-cis bonds present in the 
structures. The tables indicate the s-cis location in the polyene chain (Figure 21) by the column 
and row respectively, and ∆E  is given in kcal/mol. For example: if the first column is numbered 
2, and the row 4 the conformer is di-cis 2,4 lutein. If the first column indicates 235 and the row 7 
then the tetra-cis-2,3,5,7 lutein conformer is referred to. We have assigned the energy of the 
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predominant in nature tobe zero. That conformer is the molecule corresponding to mono-cis 1-
lutein, notice that the s-cis bond is located at the beginning of the polyene chain (Figure 22, 
Figure 23). 
Tables 4-27 show the results obtained using the PM3 calculation. 
Conformers containing one s-cis single bond 
Table 4:  Relative energies for conformers containing one s-cis single bond. 
 
 
Figure 26: Example: mono s-cis 4 lutein conformer.  
 
Conformers containing two s-cis single bonds 
Table 5: Relative energies for conformers containing two s-cis single bonds. 
s-cis 
location 1 2 3 4 5 6 7 8 9 
all- E 
lutein 
∆Energy 
kcal/mol  0 -0.7644 2.7274 -0.6113 3.002 1.5183 0.1606 1.5491 0.3746
 
 
0.5387
s-cis 
location/ 
∆E 
(kcal/mol)  2 3 4 5 6 7 8 9
1 0.2374 2.1976 -1.0314 2.4799 0.6376 0.2729 0.6117 0.4105
2   1.9600 -1.8991 1.9954 0.2798 -1.1254 -0.0537 -0.9086
3     1.6728 5.1335 3.6838 2.4816 3.8212 2.6000
4       2.2157 0.5759 -0.9789 0.5994 -0.8073
35 
 
Table 5 continues: 
 
 
Figure 27: Example: di s-cis 2,5 lutein conformer. 
 
Conformers containing three s-cis single bonds 
Table 6: Relative energies for conformers containing three s-cis single bonds. 
 
 s-cis 
location/ 
∆E 
(kcal/mol) 3 4 5 6 7 8 9
12 2.1239 -1.4354 2.4041 0.538 -0.8199 0.5504 -0.6838
13   1.5598 4.7342 2.8581 1.821 3.1677 1.9632
14     1.7444 0.1922 -1.3675 0.111 -1.2193
15       3.5971 2.0585 2.4551 2.2535
16         0.2948 2.0545 0.4807
17           1.5215 0.062
18             0.4827
 
 
 
 
2 3 4 5 6 7 8 9
5         4.2252 -0.036 3.0676 1.315
6           1.1925 2.8143 1.3394
7             2.7073 -0.056
8               1.3619
36 
 
Table 7: Relative energies for conformers containing three s-cis single bonds. 
 
 s-cis location/ 
∆E(kcal/mol) 4 5 6 7 8 9
23 0.9026 4.4566 3.3257 1.7236 3.0586 1.8218
24   1.0048 -0.6424 -2.2371 -0.6756 -2.0602
25     2.8725 1.6004 2.8764 1.7667
26       -0.2303 1.4826 0.0477
27         0.1396 -1.3009
28           0.0362
 
Table 8: Relative energies for conformers containing three s-cis single bonds. 
 
 s-cis location/ 
∆E(kcal/mol) 5 6 7 8 9 
34 5.0609 2.5288 1.3426 2.6144 1.5149 
35   6.2409 4.7733 6.1011 4.9292 
36     3.0945 4.8855 3.5 
37       4.0485 2.3182 
38         3.5441 
 
Table 9: Relative energies for conformers containing three s-cis single bonds. 
 
 s-cis location/ 
∆E(kcal/mol) 6 7 8 9
45 2.455 1.757 2.9931 1.9936
46   0.0517 1.7433 0.3442
47     0.3476 -1.1515
48       0.2527
 
Table 10: Relative energies for conformers containing three s-cis single bonds. 
 
 s-cis location/ 
∆E(kcal/mol) 7 8 9
56 3.8735 5.5269 4.0618
57   1.796 -0.2219
58     2.8145
67   2.55 1
68     2.5598
78     1.5593
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Figure 28: Example: tri s-cis 3,7,9 lutein conformer. 
 
Conformers containing four s-cis single bonds 
Table 11: Relative energies for conformers containing four s-cis single bonds. 
 
  s-cis 
location / 
∆E 
(kcal/mol) 4 5 6 7 8 9
123 0.891 4.3172 2.7676 1.4953 2.8415 1.6552
124   0.8519 -0.7478 -2.2994 -0.8455 -2.1818
125     2.8691 0.2344 1.7645 1.6992
126       -0.1139 1.444 0.0031
127         -0.0171 -1.484
128           -0.0298
134   4.5207 2.0724 0.5046 1.7316 0.8168
135     5.3864 3.8934 4.6839 4.6046
136       2.5975 4.8767 3.3819
137         3.6693 1.7748
138           2.4645
145     2.6742 1.4906 2.752 1.5318
146       -0.074 1.4571 -0.0159
147         -0.0803 -1.5653
148           -0.0731
156       3.5572 4.1199 3.7065
157         4.1322 1.0315
158           2.4942
167         2.2851 0.6476
168           2.1906
178           0.804
38 
 
Table 12: Relative energies for conformers containing four s-cis single bonds. 
 
s-cis location/ 
∆E(kcal/mol) 5 6 7 8 9 
234 3.4489 1.6584 0.5832 1.9288 0.729 
235   5.3743 4.1745 5.3789 4.2424 
236     2.5971 4.4577 3.113 
237       3.5382 1.5484 
238         2.796 
245   1.7451 0.5239 1.7278 0.7652 
246     -1.2147 0.4745 -0.887 
247       -0.9227 -2.4335 
248         -0.9534 
256     2.5609 4.1602 2.684 
257       2.7431 1.405 
258         2.6349 
267       1.5175 -0.4189 
268         1.2014 
278         -0.0572 
 
Table 13: Relative energies for conformers containing four s-cis single bonds. 
 
s-cis location/ 
∆E(kcal/mol) 6 7 8 9
345 4.894 4.5533 5.7078 4.8054
346   2.01 3.5202 2.2922
347     2.226 1.1479
348       2.3368
356   5.8798 7.3713 6.0545
357     5.85172 4.5883
358       5.8524
367     4.3631 2.8765
368       4.6341
378       3.5274
 
Table 14: Relative energies for conformers containing four s-cis single bonds. 
 
s-cis location/ 
∆E(kcal/mol) 7 8 9
456 2.1081 3.4651 2.2871
457   2.8032 1.5687
458     2.7528
467   1.6121 -0.1375
39 
 
Table 14 continues: 
7 8 9
468     1.4659
478     0.1004
567   5.4027 3.6851
568     5.2868
578     1.4516
678     2.2355
 
  
Figure 29: Example: tetra s-cis 2,4,7,9 lutein conformer. 
 
Conformers containing five s-cis single bonds 
Table 15: Relative energies for conformers containing five s-cis single bonds. 
 
 s-cis location/ 
∆E(kcal/mol)  5 6 7 8 9 
1234 4.1458 1.5726 0.4266 1.8952 0.6718 
1235   5.3192 4.0035 5.2992 4.1063 
1236     2.6439 4.3776 3.0791 
1237       3.2642 1.2891 
1238         2.6867 
1245   1.726 0.5491 1.7905 0.6148 
1246     -1.0246 0.5048 -0.8857 
1247       -0.9936 -1.4938 
1248         -1.0038 
1256     2.5619 3.1239 2.7009 
40 
 
Table 15 continues: 
5 6 7 8 9 
1257       3.4689 -0.0008 
1258         1.5665 
1267       1.2552 -0.3854 
1268         1.2258 
1278         -0.2397 
 
Table 16: Relative energies for conformers containing five s-cis single bonds. 
 
s-cis location/ 
∆E(kcal/mol)  6 7 8 9
1345 4.745 4.2102 4.6313 4.402
1346   1.7095 4.8767 1.8766
1347     1.6804 0.5461
1348       1.5181
1356   5.6351 6.6292 5.1946
1357     6.2012 3.8939
1358       5.1679
1367     3.9311 3.8939
1368       4.5984
1378       3.0017
1456   2.3477 3.8456 2.4948
1457     3.4478 1.2961
1458       2.5098
1467     1.4401 -0.3649
1468       1.2254
1478       -0.2372
1567     4.8533 3.3456
1568       4.8819
1678       2.1387
 
 
Table 17: Relative energies for conformers containing five s-cis single bonds. 
 
s-cis location/ 
∆E(kcal/mol)  6 7 8 9
2345 4.2487 3.075 4.3159 3.2456
2346   1.2031 2.8189 0.4318
2347     1.5336 0.3886
2348       1.6271
41 
 
Table 17 continues: 
6 7 8 9
2356   5.0534 6.6212 5.1865
2357    5.2466 3.9505
2358     5.1506
2367    3.5462 2.3872
2368     4.1668
2378     3.0161
2456   1.3459 2.968 1.5177
2457    1.5518 0.3425
2458     1.4685
2467     0.3582 -1.4008
2468       0.2191
2478       -1.2093
2567     5.2902 2.3739
2568       3.9208
2578       2.4988
2678       1.1785
 
Table 18: Relative energies for conformers containing five s-cis single bonds. 
 
s-cis location/ 
∆E(kcal/mol)  7 8 9
3456 4.5607 6.193 4.7207
3457   4.9047 4.3513
3458     5.4283
3467   3.8136 1.8258
3468     3.2204
3478     1.9921
3567   6.5296 5.6974
3568     6.5772
3578     5.611
3678     4.0288
4567   3.4767 1.943
4568     3.1782
4578     3.1782
4678     1.279
5678     5.0578
42 
 
 
Figure 30: Example: penta s-cis 2,4,6,7,8 lutein conformer. 
 
Conformers containing six s-cis single bonds 
Table 19: Relative energies for conformers containing six s-cis single bonds. 
 
s-cis location/ 
∆E(kcal/mol)   6 7 8 9
12345 4.453 6.5185 4.8319 3.9057
12346   1.2583 2.8212 1.4489
12347     1.4377 0.2827
12348       1.6407
12356   4.9201 6.5185 5.1402
12357     3.861 3.8189
12358       5.2608
12367     3.4618 2.3996
12368       5.1402
12378       2.5247
12456   1.3826 2.9358 1.5565
12457     2.5375 0.3891
12458       1.598
12467     0.4022 -1.219
12468       0.2868
12478       -1.0997
12567     3.8902 2.3513
12568       3.8987
12578       3.203
12678       1.1188
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Table 20: Relative energies for conformers containing six s-cis single bonds. 
 
s-cis location/ 
∆E(kcal/mol)   7 8 9
13456 4.4828 5.9184 4.4569
13457   4.2959 1.2269
13458     5.1771
13467   3.1152 1.6005
13468     3.2506
13478     1.5135
13567   6.2477 5.6817
13568     6.9354
13578     4.9041
13678     3.8372
14567   3.6349 2.1273
14568     3.6564
14578     3.3434
14678     1.4457
15678     4.9115
 
Table 21: Relative energies for conformers containing six s-cis single bonds. 
 
s-cis location/ 
∆E(kcal/mol)   7 8 9
23456 3.8312 4.9189 4.0351
23457   3.9544 2.887
23458     4.0788
23467   3.8851 1.0096
23468     2.5499
23478     1.3016
23567   6.556 4.8591
23568     6.3913
23578     5.0023
23678     3.2613
24567   3.0456 1.1578
24568     2.7271
24578     1.3186
24678     0.0425
25678     4.0707
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Table 22: Relative energies for conformers containing six s-cis single bonds. 
 
s-cis location/ 
∆E(kcal/mol)    8 9
34567 7.1866 4.3861
34568   5.8982
34578   4.6781
34678   3.3729
35678   6.2676
45678   3.0356
 
 
Figure 31: Example: hexa s-cis 3,4,5,6,7,8 lutein conformer. 
 
Conformers containing seven s-cis single bonds 
Table 23: Relative energies for conformers containing seven s-cis single bonds. 
 
s-cis location/ 
∆E(kcal/mol)    7 8 9
123456 4.1748 5.3929 4.0519
123457   5.2741 3.133
123458     4.5018
123467   2.6269 1.0052
123468     2.5759
123478     1.2664
123567   6.4002 4.7895
123568     6.3039
123578     5.5254
123678     3.2605
124567   2.6986 1.1635
45 
 
Table 23 continues: 
7 8 9
124568     2.6661
124578     2.3972
124678     0.4631
125678     3.957
134567   5.4869 3.8966
134568     5.7017
134578     5.7188
134678     2.8482
135678     6.7334
145678     3.6977
 
 
Table 24 Relative energies for conformers containing seven s-cis single bonds. 
 
 s-cis location/ 
∆E(kcal/mol)    8 9
234567 5.1413 3.6442
234568   4.6401
234578   3.735
234678   3.735
235678   6.2518
245678   2.6293
345678   5.9604
 
 
Figure 32: Example: hepta s-cis 1,3,4,5,6,7,9 lutein conformer. 
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Conformers containing eight s-cis single bonds 
Table 25 Relative energies for conformers containing eight s-cis single bonds. 
 
 
 
 
 
Table 26 Relative energies for conformers containing eight s-cis single bonds. 
 
 
 
 
 
Figure 33: Example: octa s-cis 2,3,4,5,6,7,8,9 lutein conformer. 
 
Conformer containing nine s-cis single bond 
Table 27 Relative energies for the conformer with nine s-cis single bonds. 
 
s-cis location 123456789
∆Energy (kcal/mol)  5.2324
 
s-cis 
location 12345678 12345679 12345689 12345789 12346789
∆Energie 
(kcal/mol) 5.0392 3.7859 5.2398 5.3723 2.5761
s-cis location 12356789 12456789 13456789 23456789
∆Energie (kcal/mol) 6.3434 2.7517 5.6877 4.8792
47 
 
 
Figure 34: Example: nona s-cis 1,2,3,4,5,6,7,8,9 lutein conformer. 
 
2.3.3. Calculations for the complete carotenoid model using B3*LYP/6-31G*. 
From among all the conformers that the model can have we selected some of the 
conformers to compare the calculations run with the semi-empirical PM3 method and the 
B3*LYP method. The results are shown is Table 28. 
Table 28: Calculations with B3*LYP for selected conformers of the lutein model. 
Conformer E (kcal/mol) ∆E  
lutein -1073692.21 0.00
all-E lutein -1073689.81 2.39
2 -1073687.09 5.12
3 -1073685.34 6.87
4 -1073687.43 4.78
5 -1073685.93 6.28
6 -1073685.89 6.32
7 -1073687.26 4.95
8 -1073685.48 6.73
9 -1073687.25 5.15
24 -1073684.05 8.16
26 -1073682.80 9.41
27 -1073684.04 8.15
35 -1073681.17 11.04
49 -1073683.60 7.92
48 
 
56 -1073680.69 11.51
68 -1073681.32 10.89
247 -1073680.67 11.54
248 -1073679.40 12.81
249 -1073680.88 11.33
368 -1073676.47 15.74
379 -1073679.44 12.77
479 -1073679.99 11.35
489 -1073680.03 12.18
1269 -1073681.47 10.74
2479 -1073677.43 14.78
3568 -1073670.95 21.26
4678 -1073675.00 17.20
13489 -1073677.36 14.84
23456 -1073670.97 21.24
24678 -1073671.53 20.68
234568 -1073665.08 27.12
345678 -1073666.39 25.82
356789 -1073665.14 27.07
456789 -1073669.12 23.08
2356789 -1073662.61 29.60
123456789 -1708.26709 29.60
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2.3.4. Calculations for the rotational barrier of the single bonds in lutein model using the 
B3*LYP method  
Calculations to find the rotational barrier for the 4th (C12-C13) and 5th (C14-C15) bond 
were run using the B3*LYP method. Table 29 shows the results for each case and Figure 35 
shows the torsional potential for the bonds. 
Table 29: Calculations for dihedral angle for the 4th and 5th single bond in the lutein model. 
4th single bond C12-C13 5th single bond C14-C15 
dihedral angle E (kcal/mol) ∆E  E (kcal/mol) ∆E  
lutein trans (180) -1073690.89 0 -1073690.90 0
150 -1073689.51 1.38 -1073689.88 1.02
120 -1073683.90 6.99 -1073684.41 6.49
90 -1073681.55 9.35 -1073681.16 9.74
60 -1073685.34 5.55 -1073684.07 6.83
30 -1073688.42 2.47 -1073687.04 3.86
0 -1073688.70 2.19 -1073687.20 3.70
 
 
Figure 35: Energy barrier for the rotation of the single bond at the 4th and 5th bond in the lutein 
model. 
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2.4. Discussion 
Below, Figure 36 maps the energy of the lutein conformers according to the numbers of 
s-cis bonds present. From the figure, we can see that the distribution of the energies of the lutein 
conformers lay mostly between 0 and 4 kcal/mol.  
#s-cis/ 
kcal/mol 1 2 3 4 5 6 7 8 9
0-1                   
1-2                   
2-3                   
3-4                   
4-5                   
5-6                   
6-7                   
7-8                   
 
# conformers 1-4 4-8 9-12 13-17 18-22 23-27 28-31 31-35 
                  
 
  
Figure 36: The energy of the lutein conformers according to the number of s-cis bonds and their 
location within the molecule. 
 
A surprising observation is that the conformer containing 9 s-cis bonds is lower in energy 
than some others having 3 or 6 s-cis bonds in their structures. The conformer with the highest 
energy according to the PM3 method is the tetra s-cis 3568 lutein conformer and not the nona s-
cis 123456789 lutein conformer, as we might have predicted. Another result observed about the 
conformers is that the position and arrangement of the methyl groups affects the stability of the 
different conformers. In lutein we can separate s-single bonds into two groups. In the first group, 
methyl substitution at single bonds 2, 4, 7, and 9 reduces the energy differences between the s-cis 
and s-trans conformers. In contrast the second group of single bonds, those labeled 3, 5, 6, and 8 
lack a methyl resulting in a more dramatic difference in the energies of the two conformers 
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because  the alkyl chains are oriented away from each other in the s-trans conformation. Bonds 2, 
4, 7, and 9 are analogs to 2-methyl-1,3-butadiene (see Figure 21.b) and 3, 5, 6, and 8 (see Figure 
21.c) are analogs to 1,3-pentadiene.  If we take 1,3-butadiene as a reference we can say that the 
substitution at the second carbon lowers the energy for the isomerism cis-trans compared to 
substitution of a methyl group at the first carbon (1,3 pentadiene). The energies for the cis-trans 
conformers of the substituted 1,3-butadiene (Table 3) show that there is an approximate 1 
kcal/mol difference between them. Conformers with the s-cis bonds in the first group of single 
bonds have lower energy. 
 
Table 30: Correlation of ΔE (kcal/ mol) values between s-cis and s-trans conformers as 
calculated using PM3 and B3LYP/6-31G*. 
 
conformer PM3  B3LYP/6-31G*  
minimum Lutein 0.00 0.00 
 
 
One s-cis bond 
lutein trans 0.54 2.39 
2 -0.76 5.12 
4 -0.61 4.78 
7 0.16 4.95 
9 0.37 5.15 
3 2.73 6.87 
5 3.00 6.28 
6 1.52 6.32 
8 1.55 6.73 
 
 
 
Two s-cis bond 
24 -1.90 8.16 
27 -1.13 8.15 
49 -0.81 7.92 
26 0.28 9.41 
35 5.12 11.04 
56 4.23 11.51 
68 2.81 10.89 
 
Group I 
Group II 
Group I 
Group II 
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Three s-cis 
bonds 
247 -2.24 11.54 
249 -2.06 11.33 
479 -1.15 11.35 
248 -0.68 12.81 
379 2.32 12.77 
489 0.25 12.18 
368 4.89 15.74 
 
Four s-cis bonds 
1269 0.00 10.74 
2479 -2.43 14.78 
3568 7.37 21.26 
4678 1.61 17.20 
Five s-cis bonds 13489 1.52 14.84 
23456 4.25 21.24 
24678 0.36 20.68 
 
Six s-cis bonds 
234568 4.92 27.12 
345678 7.19 25.82 
356789 6.27 27.07 
456789 3.04 23.08 
Seven s-cis bond 2356789 6.25 29.60 
All s-cis 123456789 5.23 29.60 
 
Table 30 compares the ΔE values obtained using PM3 and B3LYP/6-31G* theories. 
When we compare the values using both methods, we notice that the values for and B3LYP are 
larger. But the tendency when we subdivide them is similar.  In the first group of conformers, 
those with one s-cis bond (Table 30 have a lower relative energy than those in group II. We can 
see that this tendency repeats for all of the conformers in Table 30. The relative energy of the 
conformers that possess s-cis bonds that correspond to both group I and group II are intermediate 
in value compared to the lowest and the highest relative energies. Using the values from Table 30, 
we observed a good correlation allows use of the PM3 values to predict the B3LYP/6-31G* 
relative energy for each lutein conformer. The PM3 relative energy corresponds to the variable m 
and the number of s-cis bonds is represented by n in the conformer in the equation below: 
B3LYP Energy = 4.14n + m 
Group I 
Group II 
53 
 
 
Figure 37: Correlation between the calculated B3LYP/6-31G* DE values and the predicted 
values using the formula. 
 
Figure 37 shows the correlation of the predicted values based on PM3 and the actual 
B3LYP results. The values for PM3 are not as precise as the values that are obtained using the 
density functional theory. When using the B3LYP/6-31G* theory, the values of energy in 
kcal/mol are higher than those obtained by the PM3 method.  The square of the correlation 
coefficient (R2 = 0.9828) in the graph demonstrates that quality of the formula in estimating the 
computed B3LYP value. The range of relative energies calculated is from 2 to 30 kcal/mol for the 
different conformers using the B3LYP/6-31G* theory.  The most accessible conformers are those 
that fall below 10 kcal/mol. We know that other molecules in nature readily overcome barriers of 
this magnitude and equilibration of conformations is rapid.. Cyclohexane is an example. The 
highest energy cyclohexane conformers, the twist chair, are 10.7 kcal/mol higher than the more 
preferred chair geometry. In the case of the lutein conformers, the mono and di-cis, conformers 
are below 10 kcal/mol in energy. Therefore, these conformers can co- exist although the higher 
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energy s-cis will be present in relatively small percentages by comparison to the preferred lutein 
conformer. The conformers with three s-cis bonds are in a range of 10 to 15 kcal/mol.  The rest of 
the conformers have higher values. Although, it is interesting to note that the tetra s-cis 1269 has 
energy of only 10.74 kcal/mol.  When we focus our attention on those conformers that have the s-
cis single bonds in the group one (i.e. methyls at positions: 2, 4, 7, and 9), as we mentioned 
before, we can see that the tendency is to have a lower energies  in comparison with those in the 
second group (i.e. methyls at positions: 3, 5, 6, and 8). This explains why the tetra s-cis 1269 
lutein conformer has such a low energy relative to the most stable lutein conformer. 
Figure 35 shows the rotational barriers that must be overcome for the s-cis single bonds 
to undergo interconversion to different conformations. The s-cis bonds analyzed are present at 4th 
and 5th position in the lutein model. As we mentioned before, the first one, shown in blue (4th 
position) is the analogue of  2-methyl 1,3-butadiene. Calculations made for the rotational barrier 
of this molecule [46] using ab initio quantum method show a maximum for the gauche 
conformation of 5.6 kcal/mol in the vicinity of 90-100°; and the minimum of 2.3 kcal/mol around 
45° from the syn conformation (s-cis). The second one at the 5th  position is shown in red and the 
rotational barrier for its analogue, 1,3 pentadiene was calculated using a ab initio theory at a 
MP2/6-31G* level [38]. The maximum energy is 5.9 kcal/mol for the gauche conformation at 
100° and the minimum energy is 2.6 kcal/mol at 40°. For both simple models the curves are 
similar, as is the case for the two s-cis single bonds analyzed in this study.  Although, the energy 
values of the carotenoids are higher when compared to the simple small molecule models, both of 
the curves have a similar pattern. The maximum energy in both cases was determined to be at 90° 
and the difference between them is about 0.39 kcal/mol. The higher relative energies can be 
attributed to the steric repulsions between the methyl groups in the long lutein model.  
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According to the results from the study conducted here, we propose that some of the s-cis 
conformers, that are sufficiently low in energy, exist in nature. Lutein participates in cellular 
activities and interacts with proteins and enzymes in the living systems.  As a result of these types 
of interactions at a cellular level, lutein may adapt and adjust to that biological environment by 
dynamically deforming between a number of different low energy conformers. The significance 
of this work is that we may expect carotenoids to be stabilized in different conformations by 
interaction with biological molecules. These different conformations can be expected contribute 
to the physical and chemical properties as well as the behavior of the carotenoids within the 
biological environment.  Binding of the carotenoid to a protein might readily modulate such 
important properties as excited state energies by favoring an s-cis conformer in preference to the 
native s-trans conformations.   
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CHAPTER 3: MEASUREMENT OF CAROTENOID LEVELS IN HUMAN SERUM 
 
3.1. Overview: 
Special attention has been paid to carotenoids including: lycopene, α- and β- carotenes for 
their response to minimize the risk of cancer and cardiovascular diseases. For the past two 
decades, many study trials [28, 47-49] in lutein supplementation among healthy subjects and 
patients with age-related macular disease in early and advanced stages have been carried out to 
investigate the response of lutein supplementation. Amounts of free lutein given to the subjects 
vary from 10 – 30 mg/day and the studies vary in short-term (3 months) to up to 4 years long-
term periods [30, 50]. In all the cases, the relationship between the macular pigment caotenoids 
and AMD has been consistent and therefore, it has been suggested that the risk of Age-related 
macular degeneration can be reduced by increasing the intake of lutein. Increases in the amount 
of macular pigment located in the human retina protect these tissues from damage by 
photoxidation. In addition, the effect of multinutrients (including carotenoids) has been studied in 
HIV patients [51, 52].  Consequently, lutein supplementation studies are important to the 
nutritional field. The study of carotenoid levels in human serum is well documented and different 
methods have been published [53-55]. The dietary intake of lutein in the Western human diet is 
low [56, 57].  
In this chapter, we studied six major carotenoids in human serum of subjects that participated 
in two lutein supplementation studies. We measured the carotenoid levels of lutein (L), 
zeaxanthin (Z), lycopene (lyc), β-carotene (β-C), α-carotene (α-C), β-cryptoxanthin (β-cry), and 
α-cryptoxanthin (α-cry) and determined the ratios both before and during supplementation. In 
addition, the macular pigment optical density (MPOD) of the subjects was measured by 
heterochromatic flicker photometry. The results are compared to determine the effect of the 
supplementation on elevating the MPOD of the subjects. 
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Table 31: Uv-vis data for carotenoids dissolved in ethanol [58] . 
Carotenoid λmax (nm) 
Lutein 422   445   474 
Zeaxanthin 428   450   478 
α – cryptoxanthin 423   446   473 
β – cryptoxanthin 428   450   478 
Lycopene 446   472   503 
α – carotene 423   444   473 
β – carotene 450   476 
 
3.2. Research Methodology 
3.2.1. Chemicals and instruments: 
Lutein, dionized water, ethyl alcohol (USP grade), 1-pentanol 99%, hydrochloric acid, 
and triethylamine (TEA). Hexane, dichloromethane, methanol, acetronitrile, all HPLC grade. 
High pressure liquid chromatography (HPLC) system equipment used for carotenoid analysis: 
Waters 2690 couple to a photodiode array detector (PDA) Waters 996. High pressure liquid 
chromatography (HPLC) system used for standard purification: LDC/Milton Roy CM 4000 
multiple solvent delivery system, Thermo Finnigan Spectra System UV 1000 detector. 
Ultraviolet-visible (UV-vis) spectrophotometer Cary 100 Bio. 
   
3.2.2. Subjects: 
Study I: 32 subjects (15 males and 17 females) were recruited from the FIU community 
for the study. Subjects were randomly assigned in one of the three groups: Group P1 was given 
placebo pills, and consisted of 10 subjects (4 males and 6 females). Group L1 was supplemented 
with pills containing lutein (20 mg/day), and consisted of 11 subjects (5 males and 6 females). 
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Group L2 was supplemented with diacetate lutein pills (20 mg/day), and consisted of 11 subjects 
(6 males and 5 females). Blood samples were collected before the supplementation and every 6 
weeks after supplementation for 24 weeks in total. Macular pigment optical density was measured 
by heterochromatic flicker photometry before supplementation and every 6 weeks after 
supplementation for each subject. 
Study II: 29 subjects (22 males and 7 females) were recruited from the FIU community, 
as well for this study. Subjects were randomly assigned in one of the three groups: Group P2 was 
given placebo pills, and consisted of 9 subjects (6 males and 3 females). Group L3 was 
supplemented with pills containing lutein diester (9 mg/day), and consisted of 10 subjects (8 
males and 2 females). Group L4 was supplemented with pills containing lutein diester (9 
mg/day), and additional, low level nutritional components, including lactoferrin, cassis 
extract, eyebright extract, royal jelly, coenzyme Q10.  Study II consisted of 10 subjects (8 
males and 2 females). Blood samples were collected before the supplementation and every 6 
weeks after supplementation for 24 weeks in total. Macular pigment optical density was measure 
by heterochromatic flicker photometry before supplementation and every 6 weeks after 
supplementation for each subject. 
 
3.2.3. Internal standard preparation: 
Monopentyl lutein ether (MPL) was used as an internal standard for this study. In a flask, 
we dissolved 5 mg of lutein in 20 mL of 1-pentanol, and 1% v/v of hydrochloric acid was added. 
The reaction was placed for 3 hours in the dark and under stirring. Then, the solution was 
extracted three times with a solution of dichloromethane and deionized water (1:1). The product 
was concentrated and redissolved with ethanol to be purified by reversed phase HPLC. The 
concentration was determined by UV-visible spectrophotometry.  
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3.2.4. Serum extraction: 
Blood samples were collected from the subjects and the serum was separated by 
centrifugation. The serum samples were collected in 2mL polypropylene vials, labeled, and stored 
at -80°C in the freezer. The carotenoids were extracted according to previous published technique 
[53]. The sample was thawed at room temperature and vortexed. An aliquot of 200µL of serum 
was placed in a glass tube, 35 µL of MPL and 2 mL of a mixture of ethanol/dionized water (1:1) 
was added to the tube. The tube was vortexed for 30 seconds and carotenoids were extracted three 
times with 2 mL of hexane. For every extraction the tube was vortexed and centrifuged for 5 
minutes. The top layer of the separation was removed every time and collected in a 2mL vial.  
The aliquot obtained was dried under nitrogen gas flow. The sample was redissolved in 50 µL of 
ethanol and transfered to a vial for HPLC injection. 
 
3.2.5. Carotenoid analysis: 
The samples were analyzed by reversed phase HPLC, using a Phenomenex ODS 
ultracarb 3 µm column (20) of 250 x 4.60mm.  The mobile phase was a mixture of 
acetonitrile/methanol/TEA (85% : 15% : 0.1% v/v). The flow rate was 1 mL/minute and the 
sample was run at 30°C for 70 minutes. The results were obtained from the chromatogram and 
peaks were labeled consistent with their retention time. 
 
3.2.6. MPOD measurements  [59, 60]: 
The heterochromatic flicker photometry (HFP) is the method used to determine the 
MPOD. It can determine the spectral sensitivity of a human eye. In heterochromatic flicker 
photometry, lights of different spectral composition are alternated, and the subject has to adjust 
their relative radiances until the sensation of flicker is minimized or abolished. The two spectral 
mixtures are then defined as of equal luminance for that observer. To define a spectral sensitivity 
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function, different monochromatic lights (460 and 540 nm, in this case) are alternated with some 
standard. The flicker frequency is also an important parameter for the response to be reliable. The 
response defines the human photopic luminosity function that represents the measure of the 
average human visual sensitivity. The function is measure in two visual fields: small (2°) and 
large (10°). When it is measured using the small visual field it has an effect on the macular 
pigment but is quite insignificant in the large field. Therefore the difference of both functions 
gives a measure of the MPOD. 
The subject’s eye was covered with an eye patch and the subject was allowed to fix the focus 
of the stimulus with a hand-controlled button. Looking at the center of the stimulus the subject 
adjusts the setting until a flicker null is perceived and the wedge setting is recorded. This method 
is repeated five times in each: the small and large visual field. The MPOD of each subject were 
measured before and six weeks each time after supplementation for a total of 24 weeks period. 
 
3.3. Results: 
3.3.1. Characterization of the standard 
The UV-Visible spectrum shown below corresponds to the standard prepared.  
 
Figure 38: Monopentyl lutein UV-visible spectrum. 
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The spectrum is the same as that of lutein. The concentration of the standard was 
determinate using the Beer-Lambert law with the absorbance response at 450nm. 
   
3.3.2. Baseline 
The chromatogram below is a characteristic serum response of one of the subjects in the 
studies. The peaks were assigned according to their UV-visible spectra. 
 
Figure 39: HPLC chromatogram of serum from subject before supplementation.  
1) lutein metabolites. 2) lutein. 3) zeaxanthin. 4) α – cryptoxanthin. 5) β – cryptoxanthin. 6) MPL.  
7)lycopene. 8) α – carotene. 9) β – carotene. 
 
 
The picture below shows the expanded chromatogram from 0 – 12 minutes. The macula 
pigment carotenoids peaks are shown. 
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Figure 40: Expanded HPLC chromatogram of serum from subject before supplementation 
a) unknown. b) oxolutein. c) unknown d) 9Z lutein. 
 
 
 
Table 32: Retention time of carotenoids in human serum. 
Carotenoid Retention time (min) 
Lutein metabolites 8.00-9.00 
Lutein 9.85 
Zeaxanthin 10.61 
α – cryptoxanthin 17.13 
β – cryptoxanthin 26.88 
Monopentyl lutein ether (MPL) 30.61 
Lycopene 40.35 
α – carotene 66.21 
β – carotene 73.08 
 
The distribution of the carotenoids in serum at baseline for all the groups that participate 
in both studies is shown below (for numeric values, refer to table 34). 
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Figure 41: Distribution of the carotenoids at baseline according to the group. 
P1,placebo study 1. P2, placebo study II. L1 and L2, correspond to study I.  
L3 and L4, correspond to study II.  
 
The ratios for lutein/zeaxanthin at baseline for all the studied groups vary between 2.2 to 2.8.  
Table 33: Lutein/ zeaxanthin ratios for each study group.  
P1 L1 L2 P2 L3 L4 
L/Z 2.36 2.77 2.77 2.35 2.33 2.16
 
Table 34: Characteristic serum concentrations of carotenoids at baseline.  
Study I Study II 
Carotenoid 
concentration/ 
study group 
P1 L1 L2 P2 L3 L4 
 Lutein  
(ng/μL)  
0.21± 0.06 0.16 ± 0.07 0.12 ± 0.03 0.16 ± 0.05 0.15 ± 0.09 0.13 ± 0.05 
Zeaxanthin 
(ng/μL) 
0.09 ± 0.07 0.06 ± 0.04 0.05 ± 0.01 0.07 ± 0.02 0.07 ± 0.04 0.06 ± 0.02 
α-crytoxanthin  
(ng/μL) 
0.05 ± 0.02 0.05 ± 0.04 0.04 ± 0.02 0.06 ± 0.04 0.05 ± 0.02 0.05 ± 0.02 
β-cryptoxanthin 
(ng/μL) 
0.13 ± 0.09 0.09 ± 0.07 0.10 ± 0.09 0.09 ± 0.04 0.10 ± 0.07 0.08 ± 0.04 
α-carotene 
(ng/μL) 
0.05 ± 0.03 0.06 ± 0.05 0.04 ± 0.03 0.03 ± 0.01 0.09 ± 0.08 0.05 ± 0.02 
β-carotene 
(ng/μL) 
0.11 ± 0.07 0.10 ± 0.10 0.11 ± 0.10 0.05 ± 0.03 0.11 ± 0.09 0.11 ± 0.10 
0.00
0.05
0.10
0.15
0.20
0.25
0.30
Lut zea α-cry β-cry α-car β-car 
Carotenoid's Baseline
P1
L1
L2
P2
L3
L4
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No statistical difference was found between any of the groups at the baseline level when 
analyzed the data by one-way ANOVA (p > 0.60). 
 
3.3.3. Supplementation Response 
The supplementation responses were recorded every 6 weeks for a period of 24 weeks.  
For a better understanding the data is presenting by groups.  
 Study I: 
P1 group (placebo) 
Table 35: Carotenoid concentrations in P1 throughout the study period (mean ± standard 
deviation). 
 Week 
 Lut    
(ng/μL) 
zea    
(ng/μL) 
α-cry  
(ng/μL) 
β-cry 
(ng/μL) 
α-car 
(ng/μL) 
β-car 
(ng/μL) 
6 0.19 ± 0.06 0.07 ± 0.03 0.05 ± 0.03 0.15 ± 0.11 0.03 ± 0.02 0.09 ± 0.08 
12 0.23 ± 0.11 0.07 ± 0.04 0.07 ± 0.05 0.13 ± 0.09 0.04 ± 0.02 0.05 ± 0.06 
18 0.20 ± 0.11 0.06 ± 0.03 0.08 ± 0.06 0.09 ± 0.07 0.03 ± 0.02 0.04 ± 0.04 
24 0.15 ± 0.06 0.06 ± 0.02 0.06 ± 0.04 0.09 ± 0.09 0.06 ± 0.07 0.06 ± 0.06 
 
No statistical difference (p > 0.09) was found between the baseline and the response after 
supplementation for all the carotenoids in this group. 
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Figure 42: Comparison of carotenoids concentration in placebo group P1.  
Numeric values are shown in table 4.   
 
 
L1 group 
Table 36: Carotenoid concentrations after supplementation with L1 (mean ± standard deviation). 
 Week 
 Lut    
(ng/μL) 
zea    
(ng/μL) 
α-cry  
(ng/μL) 
β-cry 
(ng/μL) 
α-car 
(ng/μL) 
β-car 
(ng/μL) 
6 0.67 ± 0.35 0.09 ± 0.05 0.05 ± 0.02 0.09 ± 0.09 0.03 ± 0.01 0.08 ± 0.04 
12 0.72 ± 0.37 0.14 ± 0.06 0.06 ± 0.03 0.09 ± 0.07 0.08 ± 0.08 0.03 ± 0.01 
18 0.68 ± 0.46 0.14 ± 0.11 0.09 ± 0.05 0.08 ± 0.07 0.06 ± 0.04 0.06 ± 0.04 
24 0.57 ± 0.28 0.13 ± 0.07 0.06 ± 0.03 0.06 ± 0.05 0.05 ± 0.06 0.04 ± 0.02 
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Figure 43: Comparison of carotenoids concentration in L1 group. 
Numeric values are shown in table 5.   
 
For lutein: p < 0.001, and for zeaxanthin: p < 0.007. There was a significant statistical 
difference when the subjects were compared to baseline. For the rest of the carotenoids: p > 0.20, 
no statistical difference exists when compared to baseline. 
 
L2 group 
Table 37: Carotenoid concentrations after supplementation in L2 (mean ± standard deviation). 
week 
 Lut    
(ng/μL)  
zea    
(ng/μL) 
α-cry  
(ng/μL) 
β-cry 
(ng/μL) 
α-car 
(ng/μL) 
β-car 
(ng/μL) 
6 0.65 ± 0.37 0.08 ± 0.04 0.05 ± 0.02 0.11 ± 0.21 0.03 ± 0.02 0.06 ± 0.05 
12 0.76 ± 0.58 0.16 ± 0.08 0.07 ± 0.02 0.13 ± 0.15 0.01 ± 0.01 0.05 ± 0.02 
18 0.69 ± 0.60 0.12 ± 0.10 0.07 ± 0.04 0.11 ± 0.12 0.03 ± 0.01 0.06 ± 0.05 
24 0.60 ± 0.40 0.09 ± 0.05 0.06 ± 0.03 0.10 ± 0.10 0.04 ± 0.02 0.10 ± 0.08 
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Figure 44: Comparison of carotenoids concentration in L2 group. 
Numeric values are shown in table 6.   
 
For lutein and for zeaxanthin: p < 0.001. There was a significant statistical difference 
when the subjects were compared to baseline. For the rest of the carotenoids (except for α-
cryptoxanthin) : p > 0.20, no statistical difference exists when compared to baseline. For α-
cryptoxanthin: p > 0.04. 
 
MPOD results: 
The MPOD rate for each study group is summarized in table 7: 
Table 38: MPOD rates for each group (mean ± standard deviation) in study I. 
 P1 L1 L2 
Rate of MPOD 
increase 
(AU/day) 
-0.0008 ± 0.0014 0.0017 ± 0.0011 0.0019 ± 0.0005 
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Study II: 
P2 group (placebo) 
Table 39: Carotenoid concentrations after supplementation in P2 (mean ± standard deviation). 
week 
 Lut    
(ng/μL) 
zea    
(ng/μL) 
α-cry  
(ng/μL) 
β-cry 
(ng/μL) 
α-car 
(ng/μL) 
β-car 
(ng/μL) 
6 0.16 ± 0.08 0.07 ± 0.03 0.05 ± 0.04 0.11 ± 0.06 0.04 ± 0.04 0.05 ± 0.03 
12 0.18 ± 0.05 0.08 ± 0.03 0.06 ± 0.04 0.13 ± 0.08 0.05 ± 0.01 0.04 ± 0.02 
18 0.19 ± 0.10 0.08 ± 0.03 0.07 ± 0.06 0.13 ± 0.07 0.04 ± 0.00 0.05 ± 0.03 
24 0.17 ± 0.07 0.08 ± 0.02 0.07 ± 0.07 0.12 ± 0.08 0.03 ± 0.01 0.05 ± 0.02 
 
 
Figure 45: Comparison of carotenoids concentration in P2 group. 
Numeric values are shown in table 7.   
 
No statistical difference (p > 0.10) was found between the baseline and the response after 
supplementation for all the carotenoids in this group. 
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L3 group  
Table 40: Carotenoid concentrations after supplementation in L3 (mean ± standard deviation). 
week 
 Lut    
(ng/μL) 
zea    
(ng/μL) 
α-cry  
(ng/μL) 
β-cry 
(ng/μL) 
α-car 
(ng/μL) 
β-car 
(ng/μL) 
6 0.24 ± 0.11 0.07 ± 0.03 0.04 ± 0.01 0.12 ± 0.07 0.12 ± 0.10 0.09 ± 0.08 
12 0.27 ± 0.18 0.08 ± 0.03 0.05 ± 0.04 0.10 ± 0.05 0.03 ± 0.00 0.05 ± 0.02 
18 0.27 ± 0.09 0.10 ± 0.03 0.05 ± 0.02 0.11 ± 0.05 0.04 ± 0.04 0.07 ± 0.06 
24 0.30 ± 0.13 0.10 ± 0.04 0.05 ± 0.02 0.12 ± 0.05 0.03 ± 0.00 0.05 ± 0.03 
 
 
Figure 46: Comparison of carotenoids concentration in L3 group. 
Numeric values are shown in table 8.   
 
For lutein: p < 0.004, there was a significant statistical difference when the subjects were 
compared to baseline. For zeaxanthin: p > 0.08, and for the rest of the carotenoids: p > 0.20, no 
statistical difference exists when compared to baseline. 
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L4 group  
Table 41: Carotenoid concentrations after supplementation in L4 (mean ± standard deviation). 
week 
 Lut    
(ng/μL) 
zea    
(ng/μL) 
α-cry  
(ng/μL) 
β-cry 
(ng/μL) 
α-car 
(ng/μL) 
β-car 
(ng/μL) 
6 0.61 ± 0.22 0.10 ± 0.02 0.06 ± 0.03 0.10 ± 0.08 0.07 ± 0.02 0.09 ± 0.04 
12 0.59 ± 0.39 0.10 ± 0.06 0.06 ± 0.03 0.11 ± 0.07 N.D. 0.07 ± 0.07 
18 0.61 ± 0.23 0.12 ± 0.05 0.06 ± 0.03 0.12 ± 0.07 0.03 ± 0.00 0.09 ± 0.08 
24 0.62 ± 0.40 0.13 ± 0.07 0.06 ± 0.02 0.12 ± 0.06 0.04 ± 0.01 0.05 ± 0.04 
 
N.D.= no data were recorded. 
 
 
Figure 47: Comparison of carotenoids concentration in L4 group. 
Numeric values are shown in table 9.   
 
For lutein: p < 0.001, and for zeaxanthin: p < 0.004. There was a significant statistical 
difference when the subjects were compared to baseline. For the rest of the carotenoids: p > 0.10, 
no statistical difference exists when compared to baseline. 
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MPOD results: 
The MPOD increase for each study group is summarized in table 11: 
Table 42: MPOD rates for each group (mean ± standard deviation) in study II. 
 P2 L3 L4 
Rate of MPOD 
increase 
(AU/day) 
0.0011 ± 0.0008 0.0011 ± 0.0012 0.0026 ± 0.0006 
 
There is no difference between the placebo group and the L3 group. 
 
3.4. Discussion: 
3.4.1. Study I: 
 
Figure 48: Comparison of lutein concentration in serum for study I. 
 
Figure 48 shows a comparison for the lutein concentration in serum between the three 
groups. According to the values during the supplementation period, the concentration of lutein in 
0.00
0.20
0.40
0.60
0.80
1.00
1.20
1.40
0 6 12 18 24
(n
g/
uL
)
week
Lutein
P1
L1
L2
72 
 
the case of the supplemented groups increases within the first 6 weeks and remains almost 
constant for the rest of the study (until week 24th is completed). It reached its maximum value 
during the 12th week of supplementation for both L1 and L2. The placebo group remains constant 
as expected.  The error bars in both cases (L1 y L2) are more than 50% of the average of the 
concentration value in each period of time. This variability is caused to the differences of the 
concentration of lutein in serum for each subject. Lutein concentrations vary from one subject to 
another as a consequence of their diet. The ANOVA run for the supplemented groups for the 
average concentration of lutein in serum during supplementation demonstrates that the results for 
L1 and L2 are highly significant different (p<0.0002) from baseline values.  
 
Figure 49: Comparison of zeaxanthin concentration in serum for study I. 
 
Figure 49 shows the comparison for zeaxanthin in the study. The concentrations are 
smaller since the ratio L/Z  in human serum is 2- 3. For the ANOVA run  like in the case of lutein 
the results were: L1 p<0.006, and for L2 p<0.0005, as similar to the lutein case shown above the 
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error is around 50% or more. Again, is because of the variability of the subjects within the 
groups. 
Table 43 summarizes the average concentration for each group after supplementation 
(weeks 6, 12, 18 and 24) in comparison with the baseline concentrations for lutein and 
zeaxanthin. 
Table 43: Concentrations for lutein and zeaxanthin in each group before and after 
supplementation in study I. 
 Lutein (ng/μL) Zeaxanthin (ng/μL) 
 P1 L1 L2 P1 L1 L2 
Baseline  0.21 ± 0.06 0.16 ± 0.07 0.12 ± 0.03 0.09 ± 0.07 0.06 ± 0.04 0.05 ± 0.01 
Average   0.19 ± 0.02 0.66 ± 0.05 0.68 ± 0.10 0.07 ± 0.01 0.13 ± 0.02 0.11 ± 0.02 
 
In Figure 50 we can see a comparison of the average concentrations for lutein and 
zeaxanthin after supplementation by groups. The increase of lutein for group L1 is around four 
times more, and for group L2 is more than five times of the corresponding to the baseline level. 
This high increase can be attributed to the fact that the supplementation given was of 20mg of 
free lutein in each case (L1 and L2). The only difference between them is the formula used for 
each pill. For zeaxanthin the amounts double the amount of the baseline.  
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Figure 50: Average concentrations for lutein and zeaxanthin after supplementation in serum for 
study I. 
 
The rate of change of MPOD was determined as the slope of a linear fit to the MPOD 
measures during the 24 weeks of supplementation (see table 38) and fixed to baseline of each 
group.. The standards deviation of the MPOD mean rate for groups L1 and P1 are larger (more 
than 60%) than for group L2 (approximately 25%). This numbers evidence the variability 
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between subjects in the groups. The levels of MPOD are smaller in comparison with the serum 
response. The correlation between the average serum levels after supplementation and MPOD 
rates is almost perfectly linear (R2=0.9997) for this study, but no significant statistical difference 
between the groups was found. 
 
Figure 51: Comparison of mean rate of MPOD for study I.  
 
 
3.4.2. Study II: 
Figure 52 illustrate the comparison of lutein concentration in serum between the study 
groups. The placebo group remains fairly constant along the study period. As seen in the first 
study, the concentration of lutein in serum for the supplemented groups increases during the first 
6 weeks and remains slightly constant for the next 18 weeks. For the L4 group the maximum 
value is reached at week sixth and the value remains constant after. For the L3 group the 
concentration continued increasing approximately 12% every six weeks after the sixth week. 
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Once again, the error bars appear to be around 50% for the supplemented groups because of the 
variability within the subjects. The ANOVA run for group L3 (p < 0.004) and for L4 (p < 0.0002) 
evidence that the results for the lutein concentrations are statistically different form the baseline 
values.  
 
Figure 52: Comparison of lutein concentration in serum for study II. 
 
Figure 53 (see below) shows the comparison for the zeaxanthin concentration between the 
groups. The concentrations as seen in the first study are lower than the ones for lutein. But in this 
case, for group L3 the ANOVA run (p > 0.08) indicates that there is not a statistically difference 
from the baseline. In the case of L4 group the ANOVA indicate that there is a significant 
difference with the baseline values (p < 0.005). 
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Figure 53: Comparison of zeaxanthin concentration in serum for study II. 
 
 
Table 44 summarizes the average concentration for each group after supplementation 
(weeks 6, 12, 18 and 24) in comparison with the baseline concentrations for lutein and 
zeaxanthin.  
Table 44: Concentrations for lutein and zeaxanthin in each group in study II. 
 Lutein (ng/μL) Zeaxanthin (ng/μL) 
 P2 L3 L4 P2 L3 L4 
Baseline  016. ± 0.05 0.15 ± 0.09 0.13 ± 0.05 0.07 ± 0.02 0.07 ± 0.04 0.06 ± 0.02 
Average   0.17 ± 0.01 0.27 ± 0.03 0.60 ± 0.08 0.08 ± 0.00 0.09 ± 0.00 0.11 ± 0.02 
 
In Figure 54 we can see a comparison of the average concentrations for lutein and 
zeaxanthin after supplementation by groups. The increase of lutein for group L3 is almost two 
times higher, and for group L4 is of almost 5 times higher than the corresponding to the baseline 
level. The increase in this case is higher for the L4 group than for the L3 group. Although the 
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supplementation level was of 9mg/day in this case for both groups, L4 supplemented formula 
results to be superior to the formula use for L3. We have to highlight the fact that the formula for 
L4 includes other vitamins. For zeaxanthin L4 increases in almost two times the amount of the 
baseline. While for L3 the increase is not significant.  
  
 
Figure 54: Average concentrations for lutein and zeaxanthin after supplementation in serum for 
study II. 
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Figure 55: Comparison of mean rate of MPOD for study II.  
 
The rate of change of MPOD was determined as the slope of a linear fit to the MPOD 
measures during the 24 weeks of supplementation (see table 42) and fixed to baseline of each 
group. The MPOD mean rate for groups P2 and L3 has similar slopes; therefore there is no 
difference of the means between these two groups. The variability of the MPOD mean rate for 
groups P2 and L3 are larger (more than 70%) than for group L4 (23%). There is a statistical 
difference between the baseline and the average of the MPOD levels for the subjects in group L4. 
Although the same amount of lutein was supplied to both groups: L3 and L4; there is a difference 
in the response.  
 
3.5. Conclusion 
According to the data collected in this study from 61 healthy subjects, the concentration 
levels of β-carotene, α-carotene, β-cryptoxanthin, and α-cryptoxanthin remain unaltered in human 
serum during the 24 weeks of study. No significant statistical difference was found in each group 
when the concentrations of the mentioned carotenoids that were studied were compared with the 
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baseline levels in intervals of six weeks after supplementation. The absorption of the major 
carotenoids in the human serum was not affected by the intake of lutein supplement pills. 
Therefore, we can infer that the biological functions of these carotenoids are not altered, either. 
Lutein supplementation has no effect on these major carotenoids in the human serum, with the 
exception of lutein and zeaxanthin. 
For the supplemented groups, the lutein concentration in human serum increased during 
the 24 weeks in both studies. The concentrations of lutein and zeaxanthin in the placebo groups 
remained at baseline levels during the study. In study I, subjects were given a 20 mg/day dose of 
free lutein. Both groups showed a positive statistical difference on the average lutein 
concentration after supplementation, reaching up to a five-fold increase. For zeaxanthin, the 
average concentration was doubled. In study II, subjects were given a 9 mg/day dose of free 
lutein. Only the group L4 reached similar concentration levels for lutein and zeaxanthin, as seen 
in study I. Although the same dose was supplied for group L3, the lutein concentration was only 
doubled and the zeaxanthin concentration levels did not differ from the baseline. In this case, we 
can conclude that the formulation used for L3 pills is not reliable. However, it should be taken 
into account that the formulation of L4 includes other vitamins that might help to improve the 
absorption of lutein in the body. Further studies have to be made to prove this idea. Although 
variability in the concentrations of lutein and zeaxanthin were observed when measured every six 
weeks, most probably due to the diet of the subjects, there was a good response when 9 mg – 20 
mg/day of lutein were supplied.  
The MPOD increased in the supplemented groups L1, L2, and L4, during the study. 
However, differences in MPOD rates of increase between the groups did not reach a statistical 
significant difference. For the placebo group P1, there is no difference when compared to the 
baseline values, as was expected. The groups P2 and L3 had similar values of MPOD rate of 
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increase, and there was no difference in the MPOD values when we compared them to their 
baselines, or between the groups. This fact agrees with the previous statement that L3 did not 
produce a significant increase in the lutein and zeaxanthin concentration levels. The increase of 
the MPOD response for the subjects in groups L1, L2, and L4 is slower in comparison with the 
increase of lutein concentration in the serum. The absorption of lutein and zeaxanthin in the 
bloodstream is faster than the transport of those carotenoids to the macula. The transport is 
associated with a selective protein-binding mechanism. This may explain the difference in the 
rate of increase of levels in serum and in MPOD.  
Studies have showed that the consumption of lutein is low in a normal human diet. In this 
study, we showed that lutein supplementation does not influence the levels of the other major 
carotenoids in the human serum. The concentration levels of lutein and zeaxanthin increased 
during supplementation. The increase of these two carotenoids can lead to increased macular 
pigment density in the eye, which helps to protect the retina from photoxidation and lower the 
risk of macular degeneration. Therefore, we can suggest that lutein is a good supplementation to 
be included in a daily diet. 
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